As of 2025-07-04, the Relative Valuation of Reviv3 Procare Co (RVIV) is 6.52 USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.76 USD, the upside of Reviv3 Procare Co based on Relative Valuation is -48.9%.
The range of the Relative Valuation is 5.26 - 7.78 USD.
| Range | Selected | |
| Trailing P/E multiples | 12.7x - 18.7x | 15.7x |
| Forward P/E multiples | 11.9x - 17.5x | 14.7x |
| Fair Price | 5.26 - 7.78 | 6.52 |
| Upside | -58.8% - -39.0% | -48.9% |
| Date | P/E |